News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
502,945 Results
Type
Article (10034)
Company Profile (175)
Press Release (492735)
Multimedia
Podcasts (21)
Webinars (7)
Section
Business (171299)
Career Advice (365)
Deals (26362)
Drug Delivery (18)
Drug Development (54250)
Employer Resources (22)
FDA (9936)
Job Trends (8953)
News (244074)
Policy (18340)
Tag
2025 Best Places to Work (6)
2026 Best Places to Work (13)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (606)
Accelerated approval (31)
ADA (21)
Adcomms (1)
Allergies (107)
Alliances (34406)
ALS (129)
Alzheimer's disease (1065)
Antibody-drug conjugate (ADC) (379)
Approvals (10665)
Artificial intelligence (434)
ASCO (167)
Autoimmune disease (283)
Automation (38)
Bankruptcy (272)
Belgium (6)
Best Places to Work (7135)
BIO (41)
Biologics (69)
BIOSECURE Act (3)
Biosimilars (147)
BioSpace Insights (30)
Biotechnology (100)
Bispecific (36)
Bladder cancer (155)
Brain cancer (43)
Breast cancer (573)
Cancer (4389)
Cardiovascular disease (266)
Career advice (297)
Career pathing (2)
CAR-T (214)
CDC (4)
CDMO (52)
Celiac Disease (4)
Cell therapy (592)
Cervical cancer (45)
Clinical research (49711)
Collaboration (1534)
Commercialization (36)
Company closure (4)
Compensation (1697)
Complete response letters (38)
COVID-19 (915)
CRISPR (84)
CRO (3)
C-suite (971)
Cystic fibrosis (94)
Data (6994)
Denatured (10)
Depression (117)
Dermatology (108)
Diabetes (409)
Diagnostics (4443)
Digital health (45)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (217)
Drug pricing (17)
Drug shortages (3)
Duchenne muscular dystrophy (200)
Earnings (75246)
Editorial (7)
Employer branding (3)
Employer resources (20)
ESMO (258)
Events (90998)
Executive appointments (802)
Eye disease (9)
FDA (12996)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (21)
Frontotemporal dementia (26)
Funding (1166)
Gene editing (161)
Generative AI (18)
Gene therapy (411)
GLP-1 (385)
Government (1067)
Grass and pollen (2)
Guidances (292)
Healthcare (9670)
Hematology (120)
HIV (63)
Huntington's disease (33)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (84)
Immunology and inflammation (155)
Immuno-oncology (94)
Indications (194)
Infectious disease (1144)
Inflammatory bowel disease (155)
Inflation Reduction Act (8)
Influenza (95)
Intellectual property (291)
Interviews (46)
IPO (12602)
IRA (8)
Job creations (2139)
Job search strategy (281)
JPM (5)
Kidney cancer (23)
Kidney disease (97)
Labor market (16)
Layoffs (112)
Leadership (4)
Legal (5279)
Licensing (82)
Liver cancer (54)
Longevity (31)
Lung cancer (619)
Lung diease (11)
Lymphoma (296)
Machine learning (34)
Management (7)
Manufacturing (691)
Marketing (27)
MASH (136)
Medical affairs (2)
Medical device (8823)
Medtech (9028)
Melanoma (24)
Mergers & acquisitions (14926)
Metabolic disorders (860)
Middle East (2)
mRNA (103)
Multiple sclerosis (125)
Multispecific (5)
NASH (4)
Netherlands (5)
Neurodegenerative disease (274)
Neuropsychiatric disorders (54)
Neuroscience (2129)
Neurotech (2)
NextGen: Class of 2026 (3339)
Non-profit (960)
Now hiring (18)
Obesity (283)
Opinion (31)
Ovarian cancer (192)
Pain (206)
Pancreatic cancer (259)
Parkinson's disease (233)
Partnered (15)
Patents (556)
Patient advocacy (4)
Patient recruitment (567)
Patient selection (69)
Peanut (35)
People (43272)
Peptides (26)
Pharmaceutical (31)
Pharmacy benefit managers (11)
Phase 1 (16191)
Phase 2 (22306)
Phase 3 (15051)
Pipeline (9485)
Policy (38)
Postmarket research (1579)
Preclinical (6835)
Press Release (35)
Prostate cancer (218)
Psychedelics (19)
Radioligand (1)
Radiopharmaceuticals (222)
Rare diseases (708)
Real estate (3260)
Recruiting (10)
Regenerative medicine (19)
Regulatory (15695)
Reports (31)
Research institute (699)
Resumes & cover letters (52)
Rett syndrome (48)
RNA editing (14)
RSV (55)
Saudi Arabia (1)
Schizophrenia (123)
Series A (216)
Series B (150)
Service/supplier (5)
Sickle cell disease (72)
Special edition (3)
Spinal muscular atrophy (94)
Sponsored (6)
Startups (2294)
Stem cells (3)
Stomach cancer (6)
Substance use disorders (17)
Supply chain (60)
Switzerland (2)
Tariffs (4)
The Weekly (11)
Vaccines (417)
Venture capital (43)
Weight loss (110)
Wet AMD (4)
Women's health (108)
Women in leadership (1)
Worklife (2)
Date
Today (27)
Last 7 days (423)
Last 30 days (2497)
Last 365 days (20005)
2026 (18404)
2025 (20005)
2024 (23637)
2023 (27240)
2022 (35532)
2021 (38230)
2020 (34498)
2019 (24026)
2018 (18151)
2017 (19377)
2016 (18546)
2015 (24829)
2014 (22070)
2013 (18601)
2012 (20697)
2011 (20858)
2010 (20702)
Location
Africa (257)
Alabama (84)
Alaska (2)
Arizona (337)
Arkansas (12)
Asia (19299)
Australia (2325)
California (13866)
Canada (3542)
China (683)
Colorado (565)
Connecticut (483)
Delaware (245)
Europe (27582)
Florida (2025)
Georgia (424)
Hawaii (4)
Idaho (47)
Illinois (833)
India (72)
Indiana (349)
Iowa (19)
Japan (488)
Kansas (117)
Kentucky (35)
Louisiana (32)
Maine (27)
Maryland (1351)
Massachusetts (9066)
Michigan (332)
Minnesota (641)
Mississippi (6)
Missouri (89)
Montana (20)
Nebraska (11)
Nevada (145)
New Hampshire (64)
New Jersey (3036)
New Mexico (12)
New York (3177)
North Carolina (1443)
North Dakota (4)
Northern California (7073)
Ohio (330)
Oklahoma (16)
Oregon (21)
Pennsylvania (2532)
Puerto Rico (26)
Rhode Island (33)
South America (425)
South Carolina (82)
South Dakota (1)
Southern California (5754)
Tennessee (141)
Texas (2282)
United States (44595)
Utah (412)
Vermont (1)
Virginia (177)
Washington D.C. (42)
Washington State (1086)
West Virginia (2)
Wisconsin (100)
Wyoming (1)
502,945 Results for "neurocrine biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare diseases
Neurocrine defends Prader-Willi drug after another patient death
Neurocrine Biosciences will conduct a new study for the rare disease drug Vykat to explore dosing and safety in patients with Prader-Willi syndrome who have complex health issues.
November 3, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Neurocrine Biosciences Reports Third-Quarter 2026 Financial Results
November 2, 2026
·
20 min read
Press Releases
Neurocrine Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
November 10, 2026
·
1 min read
Rare diseases
Deaths reported after treatment with Neurocrine’s approved Prader-Willi drug
Reports of seven deaths in patients who had taken Neurocrine Biosciences’ Vykat and the official termination of Aardvark Therapeutics’ Phase 3 trial after cardiac complications marked a tough day for the Prader-Willi syndrome community.
August 12, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results
October 12, 2026
·
2 min read
Press Releases
Neurocrine Biosciences to Spotlight Its Scientific Journey and Growing Neuropsychiatry Pipeline at 2026 NEI Fall Congress
November 3, 2026
·
17 min read
Press Releases
Neurocrine Biosciences Announces Key Leadership Hiring, Promotions
July 24, 2026
·
4 min read
Press Releases
Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia
October 16, 2026
·
15 min read
Press Releases
Neurocrine Biosciences Announces Publication in Orphanet Journal of Rare Diseases Advancing Understanding of Hyperphagia in Prader-Willi Syndrome
October 23, 2026
·
10 min read
Press Releases
Neurocrine Biosciences Appoints Samir Siddhanti Chief Business Officer
July 22, 2026
·
6 min read
1 of 50,295
Next